Applicant, as named in the Orange Book

Luye Innomind Pharma

Next listed expiry: Erzofri on 24 Sep 2039. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Erzofri NDA 216352 · 6 strengths paliperidone palmitate	paliperidone palmitate	24 Sep 2039 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.